As part of the International Thymic Malignancy Awareness month ThymicUK will be hosting a patient webinar on: Thursday 8th May, 2025 at 18:00 hrs BST/19:00 hrs CEST Autoimmune Conditions Associated with […]
Join us for a WEBINAR FOR PHYSICIANS organized by RYTHMIC* and ITMIG members, titled: 2025 Advancements in Thymic Epithelial Tumor Care Tuesday May 13th 2025 15h-16h CEST Europe-Paris/9am-10am (EDT […]
We present a recording of a lecture by Professor Enrico Ruffini (University of Turin, Torino, Italy) on the changes we can expect in the 9th Edition of the TNM classification […]
Roden AC et al. Aims Thymic epithelial tumours (TET), including thymomas and thymic carcinomas and thymic neuroendocrine neoplasms, are malignant neoplasms that can be associated with morbidity and mortality. Recently, […]
Ruffini E. et al. Introduction A tumor, node, metastasis (TNM)-based system for all types of thymic epithelial tumors (TET) was introduced in the 8th edition of the TNM classification of […]
The following is an invitation sent by Laura Abate-Daga to a webinar for thymic tumor patient organized by Italian patient society – TUTOR: On the 16th of November, 2023 at […]
Proposal of collaboration Validation of a classification system for a better prognostic stratification of recurrent thymic epithelial tumor patients Introduction We have recently published the following manuscript in JTO: Chiappetta […]
We are pleased to announce that the INTERNATIONAL COLLABORATION ON CANCER REPORTING (ICCR) has prepared the 3rd edition of the histopathological report for thymic epithelial tumors. The guide includes a […]
Dear Colleagues: As you know, neoadjuvant treatment of thymic epithelial tumors (TET) might increase their resectability. Unlike in lung carcinoma, in the thymus, the effect of neoadjuvant treatment has not […]
ITMIG is an international platform of thymic malignancies. Thymic malignancies are associated with paraneoplastic/autoimmune syndromes. MYASTHENIA GRAVIS is the most common syndrome associated with thymic malignancies. Neurologists treating myasthenia gravis […]